LORNOXICAM DRUG PROFILE PDF

Lornoxicam is a non-steroidal anti-inflammatory drug of the oxicam class with analgesic, anti-inflammatory and antipyretic properties. It is available in oral and. Lornoxicam is a nonsteroidal anti-inflammatory drug (NSAID) of the oxicam class with analgesic (pain relieving), anti-inflammatory. Lornoxicam is a nonsteroidal anti-inflammatory drug with analgesic properties From: Profiles of Drug Substances, Excipients and Related Methodology,

Author: Kazralkis Shaktikree
Country: New Zealand
Language: English (Spanish)
Genre: Environment
Published (Last): 8 August 2006
Pages: 487
PDF File Size: 8.15 Mb
ePub File Size: 20.47 Mb
ISBN: 505-3-18510-597-1
Downloads: 89536
Price: Free* [*Free Regsitration Required]
Uploader: Tazragore

Why is Lornoxicam Prescribed? Celecoxib The risk or severity of adverse effects can be increased when Celecoxib is combined with Lornoxicam.

Haloperidol The therapeutic efficacy of Haloperidol can be increased when used in combination with Lornoxicam. CS1 German-language sources de Template: Glipizide The protein binding of Glipizide can be decreased when combined with Lornoxicam.

Imidafenacin Lornoxicam may decrease the excretion rate of Imidafenacin which could result in a higher serum level. Loteprednol The risk or severity of gastrointestinal irritation can be increased when Loteprednol is combined with Lornoxicam. Diflunisal The risk or severity of adverse effects can be increased when Diflunisal is combined with Lornoxicam.

Contraindicated in patients with peptic ulcer, severe kidney impairment, and hypersensitivity.

Lornoxicam drug information | DrugsUpdate India

Didanosine Lornoxicam may decrease the excretion rate of Didanosine which could result in a higher serum level. Edetate calcium disodium anhydrous The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Edetate calcium disodium anhydrous.

TOP Related  TERJEMAH FATHUL BARI EBOOK

Certoparin The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Certoparin.

Fluvoxamine Lornoxicam may decrease the excretion rate of Fluvoxamine which could result in a higher serum level. This section may also have questions seeking help.

Flumequine Lornoxicam may increase the neuroexcitatory activities of Flumequine. Lomefloxacin Lornoxicam may increase the neuroexcitatory activities of Lomefloxacin. Cefacetrile The risk or severity of nephrotoxicity can be increased when Cefacetrile is combined with Lornoxicam.

Lornoxicam

Letaxaban The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Letaxaban. Abiraterone The metabolism of Lornoxicam can be decreased when combined with Abiraterone.

Unlike some NSAIDS, lornoxicam’s inhibition of cyclooxygenase does not lead to an increase in leukotriene formation, meaning that arachidonic acid is not moved to the 5-lipoxygenase cascade, resulting in the minimization of the risk of adverse profipe.

Idarubicin The metabolism of Lornoxicam can be decreased when combined with Idarubicin. Cyclosporine The risk or severity of renal failure and hypertension can be increased when Orofile is combined with Cyclosporine.

Hexobarbital The metabolism of Lornoxicam can be decreased when combined with Hexobarbital.

Hydroflumethiazide The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Lornoxicam.

Formoterol The metabolism of Lornoxicam can be decreased when combined with Formoterol. Benserazide Lornoxicam may decrease the excretion dtug of Benserazide which could result in a higher serum level.

Lornoxicam information from DrugsUpdate

Clobetasol The risk or severity of gastrointestinal irritation can be increased when Clobetasol is combined with Lornoxicam. Gadoteric acid Lornoxicam may decrease the lornooxicam rate of Gadoteric acid which could result in a higher serum level. Fomepizole Lornoxicam may decrease the excretion rate of Fomepizole which could result in a higher serum level.

TOP Related  SURDAS KE DOHE IN EPUB

DL-Methylephedrine Lornoxicam may decrease the excretion rate of DL-Methylephedrine which could result in a higher serum level. Leflunomide The metabolism of Lornoxicam can be decreased when combined with Leflunomide. Flosulide Nimesulide ; Aminophenols anilines: Cefetamet The risk or severity of lronoxicam can be increased when Lornoxicam is combined with Cefetamet.

Ceftezole The risk or severity of nephrotoxicity can be increased when Lornoxicam lorjoxicam combined with Ceftezole. Kebuzone The risk or severity of adverse effects can be increased when Lornoxicam is combined with Kebuzone.

Corticotropin The risk or severity of gastrointestinal irritation can be increased lornoxicak Corticotropin is combined with Lornoxicam. Isradipine The therapeutic efficacy of Isradipine can be decreased when used in combination with Lornoxicam. Metaxalone Lornoxicam may decrease lornoxicak excretion rate of Metaxalone which could result in a higher serum level. Etonogestrel Lornoxicam may decrease the excretion rate of Etonogestrel which could result in a higher serum level.

Lubiprostone Lornoxicam may decrease the excretion rate of Lubiprostone which could result in a higher serum level.